Research projects
Start of main content
Molecular therapy for Laminopathies
17th national competition for scientific and technical research
Rare diseases
Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
Abstract
The Hutchinson-Gilford syndrome of premature ageing (HGPS or PROGERIA) is a rare disease but one with devastating effects, given that it has a high rate of mortality in the first and at the beginning of the second decade of life. Research into PROGERIA is considered to be especially important with regard to understanding the molecular mechanisms that lead to ageing, as well as constituting a challenge for the development of new therapies based on greater knowledge of cellular physiology. There are a series of unknown aspects: Why does PROGERINA cause PROGERIA? How are the lamin involved and how are their interactions between proteins and with chromatin regulated? Why do different mutations of the lamin A gene give rise to different pathologies? Our preliminary studies and those of other authors support the theory that PIK3CB regulates the nuclear lamin, as when analysing which proteins are associated with CB in "pull down", we identify lamin A; the inhibition and depletion of altered lamin, the morphology of the nucleus, the structure of the chromatin and differentiation of stem cells (our preliminary data). Lamin A as well as CB alters the structure of chromatin, in the case of lamin A by binding to complex chromatin remodellers. Finally, the treatment of PROGERIA (HGPS) with farnesylation inhibitors improved the defects of the nucleus and increased the expression of CB, suggesting that this gene regulates the nuclear lamin. These signs lead us to suggest that lamin A and CB may cooperate to preserve the nuclear envelope and its function in protecting the DNA, gene expression and maintaining the structure of the chromatin. This project explores the hypothesis that lamin A and CB co-regulate chromatin structure and cooperate in maintaining the nuclear envelope and gene expression.
- Activities related
- Projects related
- News related
- Publications related
-
11
Feb
2020
Scientific Meeting Ion beam therapy. Clinical and technological challenges for the next decade Madrid, Tuesday, 11 February 2020, 19:00 hours
-
8
Apr
2024
Panel Discussion Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
-
23
Apr
2024
Session Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas
- Agenesis of the corpus callosum. Basic mechanisms and treatment 2014 Senior Researcher : Marta Nieto López Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
- Visualisation of neuronal polysomal architecture and its alterations in Huntington's Disease 2016 Senior Researcher : José Jesús Fernández Rodríguez Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
- Phenotyping of animal models of rare diseases with visual disability 2020 Senior Researcher : Lluís Montoliu José Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
End of main content